363 related articles for article (PubMed ID: 32015234)
1. Hidradenitis Suppurativa in Sweden: A Registry-Based Cross-Sectional Study of 13,538 Patients.
Killasli H; Sartorius K; Emtestam L; Svensson Å
Dermatology; 2020; 236(4):281-288. PubMed ID: 32015234
[TBL] [Abstract][Full Text] [Related]
2. Baseline Characteristics from UNITE: An Observational, International, Multicentre Registry to Evaluate Hidradenitis Suppurativa (Acne Inversa) in Clinical Practice.
Prens EP; Lugo-Somolinos AM; Paller AS; Kerdel F; Duan Y; Teixeira HD; Longcore M; Kimball AB
Am J Clin Dermatol; 2020 Aug; 21(4):579-590. PubMed ID: 32077014
[TBL] [Abstract][Full Text] [Related]
3. High prevalence of hidradenitis suppurativa symptoms in axial spondyloarthritis patients: A possible new extra-articular manifestation.
Rondags A; Arends S; Wink FR; Horváth B; Spoorenberg A
Semin Arthritis Rheum; 2019 Feb; 48(4):611-617. PubMed ID: 29751976
[TBL] [Abstract][Full Text] [Related]
4. Hidradenitis suppurativa (HS) is associated with low socioeconomic status (SES): A cross-sectional reference study.
Deckers IE; Janse IC; van der Zee HH; Nijsten T; Boer J; Horváth B; Prens EP
J Am Acad Dermatol; 2016 Oct; 75(4):755-759.e1. PubMed ID: 27453539
[TBL] [Abstract][Full Text] [Related]
5. Demographic and clinical features of hidradenitis suppurativa in Korea.
Yang JH; Moon J; Kye YC; Kim KJ; Kim MN; Ro YS; Park MY; Ahn HH; Lee MW; Lee WJ; Lee JH; Lee JB; Jang MS; Choi YS; Choi YW; Suh DH;
J Dermatol; 2018 Dec; 45(12):1389-1395. PubMed ID: 30294846
[TBL] [Abstract][Full Text] [Related]
6. Hidradenitis Suppurativa: Estimated Prevalence, Clinical Features, Concomitant Conditions, and Diagnostic Delay in a University Teaching Hospital in Buenos Aires, Argentina.
Zimman S; Comparatore MV; Vulcano AF; Absi ML; Mazzuoccolo LD
Actas Dermosifiliogr (Engl Ed); 2019 May; 110(4):297-302. PubMed ID: 30885385
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of hidradenitis suppurativa among patients with Down syndrome: a population-based cross-sectional analysis.
Garg A; Strunk A; Midura M; Papagermanos V; Pomerantz H
Br J Dermatol; 2018 Mar; 178(3):697-703. PubMed ID: 28662304
[TBL] [Abstract][Full Text] [Related]
8. Association of metabolic syndrome and hidradenitis suppurativa.
Miller IM; Ellervik C; Vinding GR; Zarchi K; Ibler KS; Knudsen KM; Jemec GB
JAMA Dermatol; 2014 Dec; 150(12):1273-80. PubMed ID: 25229996
[TBL] [Abstract][Full Text] [Related]
9. Association between hidradenitis suppurativa and hospitalization for psychiatric disorders: a cross-sectional analysis of the National Inpatient Sample.
Patel KR; Rastogi S; Singam V; Lee HH; Amin AZ; Silverberg JI
Br J Dermatol; 2019 Aug; 181(2):275-281. PubMed ID: 30422314
[TBL] [Abstract][Full Text] [Related]
10. Hidradenitis Suppurativa (HS) prevalence, demographics and management pathways in Australia: A population-based cross-sectional study.
Calao M; Wilson JL; Spelman L; Billot L; Rubel D; Watts AD; Jemec GBE
PLoS One; 2018; 13(7):e0200683. PubMed ID: 30040827
[TBL] [Abstract][Full Text] [Related]
11. Hidradenitis suppurativa epidemiology: from the first Italian registry in 2009 to the most recent epidemiology updates - Italian Registry Hidradenitis Suppurativa project 2.
Bettoli V; Cazzaniga S; Scuderi V; Zedde P; Di Landro A; Naldi L;
J Eur Acad Dermatol Venereol; 2019 Oct; 33 Suppl 6():4-6. PubMed ID: 31535758
[TBL] [Abstract][Full Text] [Related]
12. Coprevalence of Hidradenitis Suppurativa and Psoriasis: Detailed Demographic, Disease Severity and Comorbidity Pattern.
Pinter A; Sarlak M; Zeiner KN; Malisiewicz B; Kaufmann R; Romanelli M; Koenig A; Chiricozzi A
Dermatology; 2021; 237(5):759-768. PubMed ID: 33326954
[TBL] [Abstract][Full Text] [Related]
13. Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis.
Shlyankevich J; Chen AJ; Kim GE; Kimball AB
J Am Acad Dermatol; 2014 Dec; 71(6):1144-50. PubMed ID: 25440440
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of type 2 diabetes mellitus among patients with hidradenitis suppurativa in the United States.
Garg A; Birabaharan M; Strunk A
J Am Acad Dermatol; 2018 Jul; 79(1):71-76. PubMed ID: 29339240
[TBL] [Abstract][Full Text] [Related]
15. Hidradenitis Suppurativa in Patients With Inflammatory Bowel Disease: A Population-Based Cohort Study in Olmsted County, Minnesota.
Yadav S; Singh S; Edakkanambeth Varayil J; Harmsen WS; Zinsmeister AR; Tremaine WJ; Davis MD; Wetter DA; Colombel JF; Loftus EV
Clin Gastroenterol Hepatol; 2016 Jan; 14(1):65-70. PubMed ID: 25952308
[TBL] [Abstract][Full Text] [Related]
16. Overall and subgroup prevalence of acne vulgaris among patients with hidradenitis suppurativa.
Wertenteil S; Strunk A; Garg A
J Am Acad Dermatol; 2019 May; 80(5):1308-1313. PubMed ID: 30287328
[TBL] [Abstract][Full Text] [Related]
17. Delayed Diagnosis of Hidradenitis Suppurativa and Its Effect on Patients and Healthcare System.
Kokolakis G; Wolk K; Schneider-Burrus S; Kalus S; Barbus S; Gomis-Kleindienst S; Sabat R
Dermatology; 2020; 236(5):421-430. PubMed ID: 32610312
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of hidradenitis suppurativa in Germany - an observational cohort study based on a multisource approach.
Kirsten N; Petersen J; Hagenström K; Augustin M
J Eur Acad Dermatol Venereol; 2020 Jan; 34(1):174-179. PubMed ID: 31494987
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Hidradenitis Suppurativa Disease Course During Pregnancy and Postpartum.
Lyons AB; Peacock A; McKenzie SA; Jacobsen G; Naik HB; Shi VY; Hamzavi IH; Hsiao JL
JAMA Dermatol; 2020 Jun; 156(6):681-685. PubMed ID: 32347884
[TBL] [Abstract][Full Text] [Related]
20. Pediatric Hidradenitis Suppurativa: A Cross-Sectional Study on Clinical Features and Treatment Approaches.
Garcovich S; Fania L; Caposiena D; Giovanardi G; Chiricozzi A; De Simone C; Tartaglia C; Ciccone D; Bianchi L; Abeni D; Peris K
J Cutan Med Surg; 2022; 26(2):127-134. PubMed ID: 34615396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
